Efficacy and safety analysis of P-GemDOx regimen and stratified prognosis in patients with early extranodal NK/T cell lymphoma  

作　　者：XING Tongyao 邢彤瑶(Dept Hematol,1st Affil Hosp,Nanjing Med Univ,Nanjing 210029,China)

机构地区：[1]Dept Hematol,1st Affil Hosp,Nanjing Med Univ,Nanjing 210029,China

出　　处：《China Medical Abstracts(Internal Medicine)》2024年第3期185-186,共2页中国医学文摘（内科学分册英文版）

摘　　要：Objective To assess the efficacy,safety,and related prognostic factors associated with the P-GemDOx regimen as a first-line treatment for patients with early-stage extranodal natural killer (NK)/T cell lymphoma(ENKTL).

关 键 词：REGIMEN PATIENTS LYMPHOMA 

分 类 号：R733.1[医药卫生—肿瘤]